Inventor · disambiguated record
Hans Koll
Also filed as: KOLL HANS
15 granted patents·15 pending applications·322 citations·filing 1996–2024
93Inventor score
Top patents by PatentIndex Score
30 records- 0195US6391633B1Production of erythropoietin by endogenous gene activationROCHE DIAGNOSTICS GMBH·Filed 1998·Granted May 21, 2002·158 cites·22 claims
- 0290US7318918B2Interferon-alpha polypeptides and conjugatesMAXYGEN INC·Filed 2005·Granted Jan 15, 2008·11 cites·40 claims
- 0388US6346274B1Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereofROCHE DIAGNOSTICS GMBH·Filed 1996·Granted Feb 12, 2002·96 cites·28 claims
- 0488US2025263773A1Method for the determination of sequence variants of polypeptidesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0586US7659373B2Erythropoietin with high specific activityROCHE DIAGNOSTICS GMBH·Filed 2005·Granted Feb 9, 2010·17 cites·36 claims
- 0686US6544748B2Preparation of erythropoietin by endogenous gene activationROCHE DIAGNOSTICS GMBH·Filed 2001·Granted Apr 8, 2003·10 cites·33 claims
- 0784US7214532B2Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereofROCHE DIAGNOSTICS GMBH·Filed 2003·Granted May 8, 2007·9 cites·5 claims
- 0881US9272031B2Antibodies against amyloid beta 4 with glycosylation in the variable regionHOFFMANN LA ROCHE·Filed 2014·Granted Mar 1, 2016·5 cites·13 claims
- 0977US6555373B1Methods for identifying human cell lines useful for endogenous gene activation isolated human cell lines identified thereby, and uses thereofROCHE DIAGNOSTICS GMBH·Filed 2000·Granted Apr 29, 2003·4 cites·7 claims
- 1076US7531630B2Interferon-alpha polypeptides and conjugatesMAXYGEN INC·Filed 2006·Granted May 12, 2009·1 cites·27 claims
- 1173US2021371897A1Method for the determination of sequence variants of polypeptidesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1271US8906370B2Antibodies against amyloid beta 4 with glycosylation in the variable regionLOETSCHER HANSRUEDI·Filed 2006·Granted Dec 9, 2014·3 cites·13 claims
- 1371US7186529B2Preparation of erythropoietin by endogenous gene activationROCHE DIAGNOSTICS GMBH·Filed 2003·Granted Mar 6, 2007·2 cites·26 claims
- 1470US2007225205A1Interferon-alpha polypeptides and conjugatesROCHE PALO ALTO LLC·Filed 2006·Application pending·0 cites
- 1565US7541436B2Interferon-alpha polypeptides and conjugatesMAXYGEN INC·Filed 2007·Granted Jun 2, 2009·0 cites·17 claims
- 1664US7537755B2Interferon-alpha polypeptides and conjugatesMAXYGEN INC·Filed 2007·Granted May 26, 2009·0 cites·11 claims
- 1764US2015064735A1Method for the determination of sequence variants of polypeptidesHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1861US10352943B2A-fucosylation detection in antibodiesROCHE GLYCART AG·Filed 2016·Granted Jul 16, 2019·0 cites·10 claims
- 1961US2007225204A1Interferon-alpha polypeptides and conjugatesROCHE PALO ALTO LLC·Filed 2006·Application pending·0 cites
- 2060US2014302544A1A-fucosylation detection in antibodiesROCHE GLYCART AG·Filed 2014·Application pending·0 cites
- 2159US2018164325A1Immunoglobulin glycosylation pattern analysisHOFFMANN LA ROCHE·Filed 2017·Application pending·0 cites
- 2257US2004106161A1Methods for identifying tumors that are responsive to treatment with anti-ErbB2 antibodiesFiled 2003·Application pending·0 cites
- 2355US2012322093A1Method for the determination of sequence variants of polypeptidesKOLL HANS·Filed 2011·Application pending·0 cites
- 2454US6548296B1Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereofROCHE DIAGNOSTICS GMBH·Filed 1998·Granted Apr 15, 2003·6 cites·15 claims
- 2554US2008226635A1Antibodies against insulin-like growth factor I receptor and uses thereofKOLL HANS·Filed 2007·Application pending·0 cites
- 2650US2010261216A1Stability testing of antibodiesESER BIANCA·Filed 2008·Application pending·0 cites
- 2750US2012196310A1A-fucosylation detection in antibodiesJAEGER CHRISTIANE·Filed 2010·Application pending·0 cites
- 2849US2011294150A1Immunoglobulin glycosylation pattern analysisKOLL HANS·Filed 2010·Application pending·0 cites
- 2946US2011117096A1Methods for Identifying Tumors That are Responsive to Treatement With Anti-ErbB2 AntibodiesBOSSENMAIER BIRGIT·Filed 2010·Application pending·0 cites
- 3044US2012076778A1Antibodies Against Insulin-Like Growth Factor I Receptor and Uses ThereofKOLL HANS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hans Koll files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →